• Product NameArtemether
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityArtemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
• Target NameOthers
• CAS No. 71963-77-4
• Calculated MW 298.38
• Formulation C16H26O5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C
  Pathways:Others
  Receptor:Others
  Boling pt:358C
  Melting pt:86-88C
  Solubility:Ethanol: 60 mg/mL (201.09 mM); DMSO: 60 mg/mL (201.09 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Ma Y, et al. Antimicrob Agents ChemOthers. 2014 Oct;58(10):5658-65.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting